DE3586765D1 - Immunogenische hav-peptide. - Google Patents
Immunogenische hav-peptide.Info
- Publication number
- DE3586765D1 DE3586765D1 DE8585401750T DE3586765T DE3586765D1 DE 3586765 D1 DE3586765 D1 DE 3586765D1 DE 8585401750 T DE8585401750 T DE 8585401750T DE 3586765 T DE3586765 T DE 3586765T DE 3586765 D1 DE3586765 D1 DE 3586765D1
- Authority
- DE
- Germany
- Prior art keywords
- immunogenic hav
- hav peptides
- peptides
- immunogenic
- hav
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000002163 immunogen Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5768—Hepatitis A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/22—Viral peptide or viral protein
- Y10S930/223—Hepatitis related
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/649,388 US4596674A (en) | 1984-09-11 | 1984-09-11 | Immunogenic HAV peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3586765D1 true DE3586765D1 (de) | 1992-11-26 |
DE3586765T2 DE3586765T2 (de) | 1993-04-22 |
Family
ID=24604564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585401750T Expired - Fee Related DE3586765T2 (de) | 1984-09-11 | 1985-09-09 | Immunogenische hav-peptide. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4596674A (de) |
EP (1) | EP0175613B1 (de) |
JP (1) | JPS61246199A (de) |
CA (1) | CA1270099A (de) |
DE (1) | DE3586765T2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1324094C (en) * | 1985-04-03 | 1993-11-09 | Dino Dina | Hepatitis a virus vaccines |
SU1469856A1 (ru) * | 1986-07-31 | 1990-09-30 | Институт биоорганической химии им.М.М.Шемякина | Способ конструировани рекомбинантной плазмидной ДНК, кодирующей синтез полипептидных субстанций против гепатита А |
EP0270295A3 (de) * | 1986-12-03 | 1989-08-02 | Connaught Laboratories Limited | Konjugat-Impfstoff |
US5268292A (en) * | 1988-06-27 | 1993-12-07 | Robertson Betty H | Reproducible generation of high yields of hepatitis A virus by cell culture |
DK608589D0 (da) * | 1989-12-01 | 1989-12-01 | Holm Arne | Kemisk fremgangsmaade |
US5106726A (en) * | 1990-02-16 | 1992-04-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV |
DE122007000096I1 (de) * | 1992-06-25 | 2008-03-27 | Papillomavirus vakzine | |
DE4435087A1 (de) * | 1994-09-30 | 1996-04-04 | Deutsches Krebsforsch | Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen |
US20110015585A1 (en) * | 2009-07-14 | 2011-01-20 | Pal Svedman | Method and device for providing intermittent negative pressure wound healing |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4614793A (en) * | 1983-10-14 | 1986-09-30 | Merck & Co., Inc. | Hepatitis A--subunit antigen |
DE3582812D1 (de) * | 1984-03-02 | 1991-06-20 | Merck & Co Inc | Dns-fragmente welche fuer peptide kodieren, die faehig sind in vivo die synthese von antihepatitis-a-virus-antikoerpern zu induzieren. |
CA1324094C (en) * | 1985-04-03 | 1993-11-09 | Dino Dina | Hepatitis a virus vaccines |
-
1984
- 1984-09-11 US US06/649,388 patent/US4596674A/en not_active Expired - Fee Related
-
1985
- 1985-09-06 CA CA000490156A patent/CA1270099A/en not_active Expired - Fee Related
- 1985-09-09 EP EP85401750A patent/EP0175613B1/de not_active Expired - Lifetime
- 1985-09-09 DE DE8585401750T patent/DE3586765T2/de not_active Expired - Fee Related
- 1985-09-11 JP JP60201456A patent/JPS61246199A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3586765T2 (de) | 1993-04-22 |
EP0175613B1 (de) | 1992-10-21 |
EP0175613A2 (de) | 1986-03-26 |
JPS61246199A (ja) | 1986-11-01 |
EP0175613A3 (en) | 1988-06-01 |
CA1270099A (en) | 1990-06-05 |
US4596674A (en) | 1986-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI874495L (fi) | Peptidderivat. | |
FI895201A0 (fi) | Oevervakningsanordning foer en byggnads tekniska drift. | |
DE3761698D1 (de) | Dichtungsanordnung. | |
FI872117L (fi) | Taetningsanordning. | |
NO852173L (no) | Rekombinant lymfotoksin. | |
DE3778287D1 (de) | Peptidische zusammensetzung. | |
DE3789898D1 (de) | Referenzelektrode. | |
DE3683186D1 (de) | Rekombinantes humaninterleukin-1. | |
DE3786778D1 (de) | Spannungsvergleichsschaltung. | |
DE3765434D1 (de) | Dichtungsanordnung. | |
NO881384D0 (no) | Peptider. | |
NO885108L (no) | Peptider. | |
DK531986D0 (da) | Peptider | |
DK354487A (da) | Oncogen-relaterede peptider | |
DE3766420D1 (de) | Bestimmte 3-benzoyl-3-oxolactame. | |
DE3586765D1 (de) | Immunogenische hav-peptide. | |
NO853400L (no) | Polypeptidvaksiner. | |
NO871953D0 (no) | Forbedringer vedr. roekeartikler. | |
FI851488L (fi) | Peptider. | |
FI864626L (fi) | Rekombinantricintoxin. | |
NO158908C (no) | Forseglingsanordning. | |
IT8660377V0 (it) | Montapanna semplificato. | |
NO872386D0 (no) | Peptider. | |
FI860524A0 (fi) | Utvecklare foer ren aonga. | |
DE3774988D1 (de) | Peptidderivate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |